LC
GILD icon

Lourd Capital’s Gilead Sciences GILD Stock Holding History

Lourd Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-3,332
Closed -$208K – 189
2018
Q4 		$208K Sell
3,332
-102
-3% -$7.13K 0.02% 275
2018
Q3 		$265K Buy
+3,434
New +$259K 0.02% 244
2018
Q1 		– Sell
-3,592
Closed -$257K – 194
2017
Q4 		$257K Buy
+3,592
New +$273K 0.02% 272
2016
Q3 		– Sell
-2,781
Closed -$232K – 93
2016
Q2 		$232K Buy
2,781
+107
+4% +$9.5K 0.07% 99
2016
Q1 		$246K Buy
2,674
+293
+12% +$26.4K 0.03% 102
2015
Q4 		$241K Sell
2,381
-78
-3% -$8.12K 0.03% 106
2015
Q3 		$241K Buy
+2,459
New +$273K 0.03% 98

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Lourd Capital's GILD Position: Q1 2019 in Review

Lourd Capital sold out of Gilead Sciences (GILD) in Q1 2019, closing a stake of 3,332 shares — an estimated $208K sold.

Lourd Capital first reported a position in GILD in Q3 2015 and held it in 7 quarters. The position peaked at $265K in Q3 2018. 1,491 funds tracked by Wall St. Rank hold GILD as of Q1 2019.

  • Lourd Capital reported no remaining Gilead Sciences position as of Q1 2019 after selling out during the quarter.
  • Lourd Capital sold 3,332 Gilead Sciences shares in Q1 2019, an estimated $208K.
  • Lourd Capital first reported a position in Gilead Sciences in Q3 2015 and held it in 7 quarters.
  • Lourd Capital's Gilead Sciences position peaked at $265K in Q3 2018.
  • 1,491 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2019.

Based on Lourd Capital's 13F filing for Q1 2019, filed 16 Apr 2019.